• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Administration of proton pump inhibitors in patients requiring enteral nutrition.

作者信息

Wensel Terri M

机构信息

Dr. Wensel is Assistant Professor at Samford University's McWhorter School of Pharmacy, Global Drug Information Service, in Birmingham, Alabama.

出版信息

P T. 2009 Mar;34(3):143-60.

PMID:19561850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2697083/
Abstract
摘要

相似文献

1
Administration of proton pump inhibitors in patients requiring enteral nutrition.对需要肠内营养的患者使用质子泵抑制剂。
P T. 2009 Mar;34(3):143-60.
2
Enteral nutrition better than proton pump inhibitors?肠内营养优于质子泵抑制剂？
Curr Opin Crit Care. 2019 Aug;25(4):334-339. doi: 10.1097/MCC.0000000000000620.
3
Enteral administration of three proton-pump-inhibitor formulations.三种质子泵抑制剂制剂的肠内给药。
Am J Health Syst Pharm. 2008 Dec 15;65(24):2324-5. doi: 10.2146/ajhp080027.
4
The Prophylactic Effect of Proton Pump Inhibitors Combined with Enteral Nutrition for Preventing Gastrointestinal Hemorrhage after Cardiovascular Surgery in High-Risk Patients.质子泵抑制剂联合肠内营养对高危患者心血管手术后预防胃肠道出血的预防作用
Heart Surg Forum. 2019 May 8;22(3):E183-E190. doi: 10.1532/hsf.2279.
5
Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.组胺2受体拮抗剂与静脉质子泵抑制剂在儿科重症监护病房的应用：胃pH值比较
J Crit Care. 2008 Sep;23(3):416-21. doi: 10.1016/j.jcrc.2007.10.038.
6
Enteral nutrition as stress ulcer prophylaxis in critically ill patients: A randomized controlled exploratory study.肠内营养作为危重症患者应激性溃疡预防的作用：一项随机对照探索性研究。
J Crit Care. 2018 Feb;43:108-113. doi: 10.1016/j.jcrc.2017.08.036. Epub 2017 Aug 26.
7
Enteral nutrition volume is not correlated with lower respiratory tract infection in patients on mechanical ventilation.肠内营养量与机械通气患者下呼吸道感染无关。
Med Intensiva. 2017 Aug-Sep;41(6):330-338. doi: 10.1016/j.medin.2016.09.009. Epub 2017 Mar 11.
8
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.在需要长期抗炎治疗的患者中合理使用非甾体抗炎药、环氧化酶-2特异性抑制剂和质子泵抑制剂的指南。
Aliment Pharmacol Ther. 2004 Jan 15;19(2):197-208. doi: 10.1111/j.0269-2813.2004.01834.x.
9
[Efficacy of feeding pump for patients on enteral tube feeding: a systematic literature review and analysis].[肠内管饲患者使用喂养泵的疗效：系统文献综述与分析]
Korean J Gastroenterol. 2014 Feb;63(2):99-106. doi: 10.4166/kjg.2014.63.2.99.
10
Design and development of a manual pump for bolus enteral nutrition.一种用于推注式肠内营养的手动泵的设计与开发。
Endocrinol Diabetes Nutr (Engl Ed). 2018 Feb;65(2):92-98. doi: 10.1016/j.endinu.2017.09.009. Epub 2017 Dec 6.

引用本文的文献

1
Disease Burden and Spectrum of Symptoms that Impact Quality of Life in Pediatric Patients with Eosinophilic Esophagitis.嗜酸性粒细胞性食管炎患儿的疾病负担及影响生活质量的症状谱
Gastro Hep Adv. 2024 Aug 22;3(8):1054-1068. doi: 10.1016/j.gastha.2024.08.009. eCollection 2024.
2
Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing.增强给药灵活性：经鼻胃管给药或口服替戈拉赞口腔崩解片（ODT）的药代动力学特性评估
Transl Clin Pharmacol. 2024 Jun;32(2):98-106. doi: 10.12793/tcp.2024.32.e9. Epub 2024 Jun 26.
3
Medication delivery errors in outpatients with percutaneous endoscopic gastrostomy: effect on tube feeding replacement.经皮内镜胃造口术患者门诊用药输送错误：对管饲替代的影响。
Sci Rep. 2023 Dec 8;13(1):21727. doi: 10.1038/s41598-023-48629-w.
4
Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications.南非住院儿童的超说明书用药和未获许可药物使用：实践与政策影响
Pharmacy (Basel). 2023 Nov 9;11(6):174. doi: 10.3390/pharmacy11060174.
5
Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.质子泵抑制剂剂型的研发：现状、挑战与未来展望
Pharmaceutics. 2022 Sep 25;14(10):2043. doi: 10.3390/pharmaceutics14102043.
6
A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection.质子泵抑制剂临时制剂的批判性评估：正确选择溶媒的重要性。
J Pediatr Pharmacol Ther. 2022;27(7):618-624. doi: 10.5863/1551-6776-27.7.618. Epub 2022 Sep 26.
7
The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients.药剂师在吞咽困难患者最佳药物剂型选择中的作用。
J Pers Med. 2022 Aug 12;12(8):1307. doi: 10.3390/jpm12081307.
8
Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern Thailand.儿科制剂可及性差距：泰国北部一家教学医院的横断面观察研究
Children (Basel). 2022 Feb 22;9(3):301. doi: 10.3390/children9030301.
9
Comparative Stability of Compounded Omeprazole Suspension Versus Commercial Omeprazole Kit When Stored in Oral Syringes Under Refrigerated Conditions.冷藏条件下，复方奥美拉唑混悬液与市售奥美拉唑试剂盒储存在口服注射器中时的稳定性比较
J Pharm Technol. 2020 Oct;36(5):179-186. doi: 10.1177/8755122520935532. Epub 2020 Jun 26.
10
Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.质子泵抑制剂在无防腐剂悬浮剂中的相容性。
Eur J Hosp Pharm. 2018 May;25(3):150-156. doi: 10.1136/ejhpharm-2016-001034. Epub 2016 Nov 25.

本文引用的文献

1
Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.危重症患者肠内和静脉注射兰索拉唑药效学反应的比较。
Aliment Pharmacol Ther. 2008 Aug 1;28(3):326-33. doi: 10.1111/j.1365-2036.2008.03728.x.
2
'Poppy seeds' in stomach aspirates: is oral omeprazole extemporaneous dispersion bioavailable?胃抽吸物中的“罂粟籽”：口服奥美拉唑临时分散剂是否具有生物利用度？
Eur J Pediatr. 2008 Jul;167(7):823-5. doi: 10.1007/s00431-007-0567-z. Epub 2007 Jul 20.
3
Delivery of esomeprazole magnesium through nasogastric and gastrostomy tubes using an oral liquid vehicle as a suspending agent in vitro.在体外使用口服液体制剂作为悬浮剂通过鼻胃管和胃造瘘管输送埃索美拉唑镁。
Am J Health Syst Pharm. 2006 Oct 1;63(19):1882-7. doi: 10.2146/ajhp060025.
4
Failure of nasogastric omeprazole suspension in pediatric intensive care patients.儿科重症监护患者中鼻胃管给予奥美拉唑混悬液失败
Pediatr Crit Care Med. 2005 Mar;6(2):182-7. doi: 10.1097/01.PCC.0000154953.12594.9E.
5
Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution.泮托拉唑在碳酸氢钠溶液中的口服生物利用度。
Am J Health Syst Pharm. 2003 Jul 1;60(13):1324-9. doi: 10.1093/ajhp/60.13.1324.
6
Omeprazole pharmacodynamics and gastric acid suppression in critically ill pediatric transplant patients.奥美拉唑在危重症儿科移植患者中的药效学及胃酸抑制作用
Pediatr Crit Care Med. 2001 Jul;2(3):232-7. doi: 10.1097/00130478-200107000-00008.
7
Delivery of esomeprazole magnesium enteric-coated pellets through small caliber and standard nasogastric tubes and gastrostomy tubes in vitro.在体外通过小口径和标准鼻胃管及胃造瘘管输送埃索美拉唑镁肠溶微丸。
Am J Health Syst Pharm. 2002 Nov 1;59(21):2085-8. doi: 10.1093/ajhp/59.21.2085.
8
Omeprozole therapy in pediatric patients after liver and intestinal transplantation.肝肠移植术后儿科患者的奥美拉唑治疗
J Pediatr Gastroenterol Nutr. 2002 Feb;34(2):194-8. doi: 10.1097/00005176-200202000-00016.
9
Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects.兰索拉唑口服胶囊与混悬液在健康受试者中的比较药代动力学和药效学
Am J Health Syst Pharm. 2001 Aug 15;58(16):1512-9. doi: 10.1093/ajhp/58.16.1512.
10
Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.对24小时胃内pH值的影响：比较经鼻胃管给予苹果汁中兰索拉唑与静脉给予泮托拉唑的效果。
Am J Gastroenterol. 2001 Jul;96(7):2058-65. doi: 10.1111/j.1572-0241.2001.03939.x.